Lilly Endowment, Inc.
Insider · ELI Lilly & Co (LLY)
planned sales: $1,121,154,200
| Date | Trade | Shares | Avg. price | Value | Filing |
|---|---|---|---|---|---|
| October 30, 2026 | Planned sale | 295,000 | — | $405,241,500 | SEC |
| October 15, 2026 | Planned sale | 305,000 | — | $368,665,700 | SEC |
| October 7, 2026 | Planned sale | 300,000 | — | $347,247,000 | SEC |
Shown: open-market purchases and sales (Form 4, codes P and S) and notices of planned sales (Form 144), values as filed. Not shown: grants, tax withholding, gifts and option exercises — they are not trades. A disclosed trade does not show how the person rates the company and is not a recommendation.
